BCL-2 transduction, using a herpes simplex virus amplicon, protects hippocampal neurons from transient global ischemia

Experimental Neurology

Volumn 156, Issue 1, 1999, Pages 130-137

  Antonawich, Francis J ^a   Federoff, Howard J ^b   Davis, James N ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Amplicon; Bax; Bcl 2; CA1; Gene therapy; Gene transfer; Gerbil

Indexed keywords

BETA GALACTOSIDASE; PROTEIN BAX; PROTEIN BCL 2;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN PROTECTION; CELL DEATH; CONTROLLED STUDY; EXPRESSION VECTOR; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GERBIL; HERPES SIMPLEX VIRUS; HIPPOCAMPUS; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL;

EID: 0032997952     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.7004     Document Type: Article

References (52)

1. Abe K., Aoki M., Kawagoe J., Yoshida T., Hattori A., Kogure K., Itoyama Y. Ischemic delayed neuronal death: A mitochondrial hypothesis. Stroke. 26:1995;1478-1489.
2. Allsopp T. E., Wyatt S., Paterson H. F., Davies A. M. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell. 73:1993;295-307.
3. Alonso M. T., Lim F., Nunez L., Represa J., Giraldez F., Schimmang T. HSV-1 vector mediated transfer of BDNF into cerebellar granule cells. Neuroreport. 7:1996;3105-3108.
4. Antonawich F. J., Federoff H. J., Krajewski S., Reed J. C., Davis J. N. Ischemic CA1 hippocampal neurons express bax and can be rescued by bcl-2 induction with a herpes simplex virus (HSV) amplicon. Soc. Neurosci. Abstr. 22:1996;1179.
5. Antonawich F. J., Krajewski S., Reed J. C., Davis J. N. Bcl-x/Bax interaction following transient global ischemia. J. Cereb. Blood Flow Metab. 18:1998;882-886.
6. Chen J., Zhu R. L., Nakayama M., Kawaguchi K., Jin K. L., Stetler R. A., Simon R. P., Graham S. H. Expression of the apoptosis effector gene, bax, is up-regulated in vulnerable hippocampal CA1 neurons following global ischemia. J. Neurochem. 67:1996;64-71.
7. During M. J., Naegele J. R., O'Malley K. L., Geller A. I. Long-term behavioral recovery in Parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science. 266:1994;1399-1403.
8. Fink D. J., Glorioso J. C. Engineering herpes simplex virus vectors for gene transfer to neurons. Nature Med. 3:1997;357-359.
9. Fink D. J., Poliani P. L., Oligino T., Krisky D. M., Goins W. F., Glorioso J. C. Development of an HSV-based vector for the treatment of Parkinson's Disease. Exp. Neurol. 144:1997;103-112.
10. Fraefel C., Song S., Lim F., Lang P., Yu L., Wang Y., Wild P., Geller A. I. Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70:1996;7190-7197.
11. Fuxe K., Chadi G., Tinner B., Agnati L. F., Pettersson R., David G. On the regional distribution of heparan sulfate proteoglycan immunoreactivity in the rat brain. Brain Res. 636:1994;131-138.
12. Gallyas F., Wolff J. R., Bottcher H., Zaborszky L. A reliable method to localize axonal damage after axotomy. Stain Tech. 55:1980;291-297.
13. Gallyas F., Wolff J. R., Bottcher H., Zaborszky L. A reliable and sensitive method to localize terminal degeneration and lysosomes in the central nervous system. Stain Tech. 55:1980;299-306.
14. Garcia I., Martinou I., Tsujimoto Y., Martinou J. D. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science. 258:1992;302-304.
15. Geller A. I., Yu L., Wang Y., Fraefel C. Herpes virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's Disease and other neurological disorders. Exp. Neurol. 144:1997;98-102.
16. Geschwind M. D., Kessler J. A., Geller A. I., Federoff H. J. Transfer of the nerve growth factor gene into cell lines and cultures neurons using a defective Herpes Simplex virus vector: Transfer of NGF gene into cells by a HSV-1 vector. Mol. Brain Res. 24:1994;327-335.
17. Goins W. F., Krisky D. M., Marconi P., Oligino T., Ramakrishnan R., Poliani P. L., Fink D. J., Glorioso J. C. Herpes simplex virus vectors for gene transfer to the nervous system. J. Neurovirol. 3:1997;80-88.
18. Hara A., Iwai T., Niwa M., Uematsu T., Yoshimi N., Tanaka T., Mori H. Immunohistochemical detection of bax and bcl-2 proteins in gerbil hippocampus following transient forebrain ischemia. Brain Res. 711:1996;249-253.
19. Ho D. Y., Fink S. L., Lawrence M. S., Meier T. J., Saydam T. C., Dash R., Sapolsky R. M. Herpes simplex virus vector system: analysis of its in vivo and in vitro cytopathic effects. J. Neurosci. Methods. 57:1995;205-215.
20. Ho D. Y., Saydam T. C., Fink S. L., Lawrence M. S., Sapolsky R. M. Defective herpes simplex virus vectors expressing the rat brain glucose transporter protect cultured neurons from necrotic insults. J. Neurochem. 65:1995;842-850.
21. Hockenberry D. M. Defining apoptosis. Am. J. Pathol. 146:1995;16-19.
22. Hockenberry D. M., Oltvai Z. N., Yin X., Milliman C. L., Korsmeyer S. J. Bcl-2 functions in an anti-oxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
23. Ito U., Spatz M., Walker J., Klatzo I. Experimental cerebral ischemia in mongolian gerbils. Acta Neuropathol. 32:1975;209-223.
24. Kamme F., Wieloch T. The effect of hypothermia on protein synthesis and the expression of immediate early genes following transient cerebral ischemia. Adv. Neurol. 71:1996;199-206.
25. Kane D. J., Sarafian T. A., Anton R., Hahn H., Gralla E. B., Valentine J. S., Ord T., Gredesen D. E. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science. 262:1993;1274-1277.
26. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239:1982;57-69.
27. Kirino T., Sano K. Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol. 62:1984;201-208.
28. Korsmeyer S. J., Shutter J. R., Veis D. J., Merry D. E., Oltvai Z. N. Bcl-2/bax: A rheostat the regulates an anti-oxidant pathway and cell death. Cancer Biol. 4:1993;327-332.
29. Krajewski S., Mai J. K., Krajewska M., Sikorska M., Mossakowski M., Reed J. C. Upregulation of bax protein levels in neurons following cerebral ischemia. J. Neurosci. 15:1995;6364-6376.
30. Lawrence M. S., Ho D. Y., Dash R., Sapolsky R. M. Herpes simplex virus vectors overexpressing the glucose transporter gene protect against seizure-induced neuron loss. Proc. Natl. Sci. USA. 92:1995;7247-7251.
31. Lawrence M. S., Ho D. Y., Sun G. H., Steinberg G. K., Sapolsky R. M. Overexpression of bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J. Neurosci. 16:1996;486-496.
32. Linnik M. D., Zahos P., Geschwind M. D., Federoff H. J. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke. 26:1995;1670-1674.
33. Lycke E., Johansson M., Svennerholm B., Lindahl U. Binding of herpes simplex virus to cellular heparan sulphate, an initial step in the adsorption process. J. Gen. Virol. 72:1991;1131-1137.
34. Majno G., Joris I. Apoptosis, oncosis, and necrosis. Am. J. Pathol. 146:1995;3-15.
35. Martinou J. D., Dubois-Dauphin M., Staple J. K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C., Huarte J. Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron. 13:1994;1017-1030.
36. Merry D. E., Veis D. J., Hickey W. F., Korsmeyer S. J. Bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development. 120:1994;301-311.
37. Morse J. K., Davis J. N. Regulation of ischemic hippocampal damage by adrenal steroids in the gerbil: Adrenalectomy alters the rate of pyramidal cell death. Exp. Neurol. 110:1990;86-92.
38. Oltvai Z. N., Milliman C. L., Korsmeyer S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programed cell death. Cell. 74:1993;609-619.
39. Pakzaban P., Geller A. I., Isacson O. Effect of exogenous nerve growth factor on neurotoxicity of and neuronal gene delivery by a herpes simplex amplicon vector in the rat brain. Hum. Gene Ther. 5:1994;987-995.
40. Parsadanian A. S., Chen Y., Keller-Peck C. R., Holtzmann D. M., Snider W. D. Bcl-xl is an anti-apoptotic regulator for postnatal CAN neurons. J. Neurosci. 18:1998;1009-1019.
41. Raley-Susman K. M., Murata J. Time course of protein changes following in vitro ischemia in the rat hippocampal slice. Brain Res. 694:1995;94-102.
42. Reed J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1994;1-6.
43. Rubin L. L., Gatchalian C. L., Rimon G., Brooks S. F. The molecular mechanisms of neuronal apoptosis. Curr. Opinion Neurobiol. 4:1994;696-702.
44. Song S., Wang Y., Bak S. Y., Lang P., Ullrey D., Neve R. L., O'Malley K. L., Geller A. I. An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. J. Neurochem. 68:1997;1792-1803.
45. Suhr S. T., Gage F. H. Gene therapy for neurologic disease. Arch. Neurol. 50:1993;1252-1268.
46. Tsujimoto Y., Croce C. M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA. 83:1986;5214-5218.
47. Wu P., Davis J. N. DNA fragmentation isNOT. Soc. Neurosci. Abstr. 20:1994;1944.
48. Wudunn D., Spear P. G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63:1989;52-58.
49. Wyllie A. H., Beattie G. J., Hargreaves A. D. Chromatin changes in apoptosis. Histochem. J. 13:1981;681-692.
50. Wyllie A. H., Kerr J. F. R., Currie A. R. Cell death: The significance of apoptosis. Int. Rev. Cytol. 68:1980;251-302.
51. Wyllie A. H., Morris R. G. Hormone-induced cell death: Purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Adv. Neurol. 109:1982;78-87.
52. Zhang L. X., Smith M. A., Reed J. C., Clark M., Feldman A. N., Rubinow D. R., Post R. M. Ratio of Bcl-2 and Bax expression during development and apoptosis of neurons in the CNS. Soc. Neurosci. Abstr. 21:1995;559.